Characterization of sputum biomarkers for asthma–COPD overlap syndrome

@inproceedings{Gao2016CharacterizationOS,
  title={Characterization of sputum biomarkers for asthma–COPD overlap syndrome},
  author={Jing Gao and Hiroshi Iwamoto and Jukka Koskela and Harri Alenius and Noboru Hattori and Nobuoki Kohno and Tarja Laitinen and Witold Mazur and Ville P Pulkkinen},
  booktitle={International journal of chronic obstructive pulmonary disease},
  year={2016}
}
Asthma-COPD overlap syndrome (ACOS) is a commonly encountered chronic airway disease. However, ACOS is still a consensus-based clinical phenotype and the underlying inflammatory mechanisms are inadequately characterized. To clarify the inflammatory mediatypical for ACOS, five biomarkers, namely interleukin (IL)-13, myeloperoxidase (MPO), neutrophil gelatinase-associated lipocalin (NGAL), chitinase-like protein (YKL-40), and IL-6, were selected. This study hypothesized that sputum biomarkers… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 6 times over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 46 references

The asthmaCOPD overlap syndrome: towards a revised taxonomy of chronic airways diseases

  • ED Bateman, HK Reddel, RN van Zyl-Smit, A. Agusti
  • Lancet Respir Med
  • 2015
Highly Influential
10 Excerpts

GINA strategy report : opportunities for change

  • ED Bateman, HK Reddel, RN vanZyl-Smit, A Agusti
  • Curr Opin Pulm Med
  • 2015

Similar Papers

Loading similar papers…